Meropenem induced hypokalemia

T. V. Anuhya, Raviraj Acharya, Sharath Madhyastha, Ram Bhat, Veena Nayak

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Meropenam, a beta-lactam antibiotic has been used for severe infections of skin, tissue, intra- abdominal and urogenital infections in hospitalized patients. The common adverse effects reported are diarrhoea, vomiting, rashes and hypersensitivity reactions. Here we report two cases of meropenam induced hypokalemia, wherein, meropenam was prescribed for cellulitis and urinary tract infection in the first and second case respectively. Hypokalemia can manifest as muscular weakness, fatigue, muscle cramps, constipation, ileus, flaccid paralysis, hyporeflexia, hypercapnia, tetany, rhabdomyolysis or respiratory failure. Hence, it is necessary to make physicians aware of such an adverse effect which can develop with meropenam.

Original languageEnglish
Pages (from-to)OD05-OD06
JournalJournal of Clinical and Diagnostic Research
Volume11
Issue number8
DOIs
Publication statusPublished - 01-08-2017

Fingerprint

meropenem
Hypokalemia
beta-Lactams
Muscle
Skin
Fatigue of materials
Tissue
Tetany
Anti-Bacterial Agents
Intraabdominal Infections
Muscle Cramp
Abnormal Reflexes
Muscle Fatigue
Rhabdomyolysis
Cellulitis
Hypercapnia
Ileus
Muscle Weakness
Constipation
Exanthema

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

Anuhya, T. V. ; Acharya, Raviraj ; Madhyastha, Sharath ; Bhat, Ram ; Nayak, Veena. / Meropenem induced hypokalemia. In: Journal of Clinical and Diagnostic Research. 2017 ; Vol. 11, No. 8. pp. OD05-OD06.
@article{4dd0c8f0e0fc4a8680a859cff14f6ed9,
title = "Meropenem induced hypokalemia",
abstract = "Meropenam, a beta-lactam antibiotic has been used for severe infections of skin, tissue, intra- abdominal and urogenital infections in hospitalized patients. The common adverse effects reported are diarrhoea, vomiting, rashes and hypersensitivity reactions. Here we report two cases of meropenam induced hypokalemia, wherein, meropenam was prescribed for cellulitis and urinary tract infection in the first and second case respectively. Hypokalemia can manifest as muscular weakness, fatigue, muscle cramps, constipation, ileus, flaccid paralysis, hyporeflexia, hypercapnia, tetany, rhabdomyolysis or respiratory failure. Hence, it is necessary to make physicians aware of such an adverse effect which can develop with meropenam.",
author = "Anuhya, {T. V.} and Raviraj Acharya and Sharath Madhyastha and Ram Bhat and Veena Nayak",
year = "2017",
month = "8",
day = "1",
doi = "10.7860/JCDR/2017/27584.10387",
language = "English",
volume = "11",
pages = "OD05--OD06",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "8",

}

Meropenem induced hypokalemia. / Anuhya, T. V.; Acharya, Raviraj; Madhyastha, Sharath; Bhat, Ram; Nayak, Veena.

In: Journal of Clinical and Diagnostic Research, Vol. 11, No. 8, 01.08.2017, p. OD05-OD06.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Meropenem induced hypokalemia

AU - Anuhya, T. V.

AU - Acharya, Raviraj

AU - Madhyastha, Sharath

AU - Bhat, Ram

AU - Nayak, Veena

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Meropenam, a beta-lactam antibiotic has been used for severe infections of skin, tissue, intra- abdominal and urogenital infections in hospitalized patients. The common adverse effects reported are diarrhoea, vomiting, rashes and hypersensitivity reactions. Here we report two cases of meropenam induced hypokalemia, wherein, meropenam was prescribed for cellulitis and urinary tract infection in the first and second case respectively. Hypokalemia can manifest as muscular weakness, fatigue, muscle cramps, constipation, ileus, flaccid paralysis, hyporeflexia, hypercapnia, tetany, rhabdomyolysis or respiratory failure. Hence, it is necessary to make physicians aware of such an adverse effect which can develop with meropenam.

AB - Meropenam, a beta-lactam antibiotic has been used for severe infections of skin, tissue, intra- abdominal and urogenital infections in hospitalized patients. The common adverse effects reported are diarrhoea, vomiting, rashes and hypersensitivity reactions. Here we report two cases of meropenam induced hypokalemia, wherein, meropenam was prescribed for cellulitis and urinary tract infection in the first and second case respectively. Hypokalemia can manifest as muscular weakness, fatigue, muscle cramps, constipation, ileus, flaccid paralysis, hyporeflexia, hypercapnia, tetany, rhabdomyolysis or respiratory failure. Hence, it is necessary to make physicians aware of such an adverse effect which can develop with meropenam.

UR - http://www.scopus.com/inward/record.url?scp=85027271264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027271264&partnerID=8YFLogxK

U2 - 10.7860/JCDR/2017/27584.10387

DO - 10.7860/JCDR/2017/27584.10387

M3 - Article

VL - 11

SP - OD05-OD06

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 8

ER -